Literature DB >> 11527824

Significant role of interleukin-8 in pathogenesis of pulmonary disease due to Mycoplasma pneumoniae infection.

M Narita1, H Tanaka, S Yamada, S Abe, T Ariga, Y Sakiyama.   

Abstract

We found elevated levels of interleukin-8 in pleural fluid samples from patients with pleural effusion and with a sustained fibrotic change of the lung due to Mycoplasma pneumoniae infection. This result suggests a critical role of interleukin-8 in the pathogenesis of a certain type of pulmonary disease caused by M. pneumoniae.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11527824      PMCID: PMC96192          DOI: 10.1128/CDLI.8.5.1028-1030.2001

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  12 in total

1.  Severe acute lung injury caused by Mycoplasma pneumoniae: potential role for steroid pulses in treatment.

Authors:  M Radisic; A Torn; P Gutierrez; H A Defranchi; P Pardo
Journal:  Clin Infect Dis       Date:  2000-12       Impact factor: 9.079

2.  Relationships between radiological pattern and cell-mediated immune response in Mycoplasma pneumoniae pneumonia.

Authors:  H Tanaka; H Koba; S Honma; F Sugaya; S Abe
Journal:  Eur Respir J       Date:  1996-04       Impact factor: 16.671

3.  A human homologue of the Drosophila Toll protein signals activation of adaptive immunity.

Authors:  R Medzhitov; P Preston-Hurlburt; C A Janeway
Journal:  Nature       Date:  1997-07-24       Impact factor: 49.962

4.  Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells.

Authors:  A J Puren; G Fantuzzi; Y Gu; M S Su; C A Dinarello
Journal:  J Clin Invest       Date:  1998-02-01       Impact factor: 14.808

5.  Bronchiolitis obliterans organizing pneumonia associated with acute Mycoplasma pneumoniae infection.

Authors:  J M Llibre; A Urban; E Garcia; M A Carrasco; C Murcia
Journal:  Clin Infect Dis       Date:  1997-12       Impact factor: 9.079

6.  Close association between pulmonary disease manifestation in Mycoplasma pneumoniae infection and enhanced local production of interleukin-18 in the lung, independent of gamma interferon.

Authors:  M Narita; H Tanaka; S Abe; S Yamada; M Kubota; T Togashi
Journal:  Clin Diagn Lab Immunol       Date:  2000-11

7.  Mycoplasma fermentans lipoprotein M161Ag-induced cell activation is mediated by Toll-like receptor 2: role of N-terminal hydrophobic portion in its multiple functions.

Authors:  M Nishiguchi; M Matsumoto; T Takao; M Hoshino; Y Shimonishi; S Tsuji; N A Begum; O Takeuchi; S Akira; K Toyoshima; T Seya
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

8.  Open lung biopsy in Mycoplasma pneumoniae pneumonia.

Authors:  S Rollins; T Colby; F Clayton
Journal:  Arch Pathol Lab Med       Date:  1986-01       Impact factor: 5.534

Review 9.  Mycoplasma pneumoniae-associated bronchiolitis causing severe restrictive lung disease in adults: report of three cases and literature review.

Authors:  E D Chan; T Kalayanamit; D A Lynch; R Tuder; P Arndt; R Winn; M I Schwarz
Journal:  Chest       Date:  1999-04       Impact factor: 9.410

View more
  16 in total

1.  Reactive oxygen species mediate Jak2/Stat3 activation and IL-8 expression in pulmonary epithelial cells stimulated with lipid-associated membrane proteins from Mycoplasma pneumoniae.

Authors:  Sang Yong Choi; Joo Weon Lim; Takashi Shimizu; Koichi Kuwano; Jung Mogg Kim; Hyeyoung Kim
Journal:  Inflamm Res       Date:  2012-01-24       Impact factor: 4.575

2.  Effect of puerarin on the release of interleukin-8 in co-culture of human bronchial epithelial cells and neutrophils.

Authors:  Wei Pang; Xiao-Mei Lan; Cheng-Bin Wang
Journal:  Chin J Integr Med       Date:  2012-03-30       Impact factor: 1.978

3.  Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan.

Authors:  Mayumi Matsuoka; Mitsuo Narita; Norio Okazaki; Hitomi Ohya; Tsutomu Yamazaki; Kazunobu Ouchi; Isao Suzuki; Tomoaki Andoh; Tsuyoshi Kenri; Yuko Sasaki; Atsuko Horino; Miharu Shintani; Yoshichika Arakawa; Tsuguo Sasaki
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

Review 4.  Mycoplasma pneumoniae and its role as a human pathogen.

Authors:  Ken B Waites; Deborah F Talkington
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

5.  Nationwide surveillance of macrolide-resistant Mycoplasma pneumoniae infection in pediatric patients.

Authors:  Yasuhiro Kawai; Naoyuki Miyashita; Mika Kubo; Hiroto Akaike; Atsushi Kato; Yoko Nishizawa; Aki Saito; Eisuke Kondo; Hideto Teranishi; Tokio Wakabayashi; Satoko Ogita; Takaaki Tanaka; Kozo Kawasaki; Takashi Nakano; Kihei Terada; Kazunobu Ouchi
Journal:  Antimicrob Agents Chemother       Date:  2013-05-28       Impact factor: 5.191

6.  Three familial cases of drug-resistant Mycoplasma pneumoniae infection.

Authors:  Shintaro Kamizono; Hitomi Ohya; Sadanobu Higuchi; Norio Okazaki; Mitsuo Narita
Journal:  Eur J Pediatr       Date:  2009-11-08       Impact factor: 3.183

7.  Induction of IL-8 by Mycoplasma pneumoniae membrane in BEAS-2B cells.

Authors:  Kathryn Chmura; Xiyuan Bai; Mari Nakamura; Pitchaimani Kandasamy; Mischa McGibney; Koji Kuronuma; Hiroki Mitsuzawa; Dennis R Voelker; Edward D Chan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-05-16       Impact factor: 5.464

8.  Mycoplasma pneumoniae pneumonia in children.

Authors:  You-Sook Youn; Kyung-Yil Lee
Journal:  Korean J Pediatr       Date:  2012-02-14

9.  Gene and cytokine profile analysis of macrolide-resistant Mycoplasma pneumoniae infection in Fukuoka, Japan.

Authors:  Kentaro Matsuda; Mitsuo Narita; Nobuyuki Sera; Eriko Maeda; Hideaki Yoshitomi; Hitomi Ohya; Yuko Araki; Tatsuyuki Kakuma; Atsushi Fukuoh; Kenji Matsumoto
Journal:  BMC Infect Dis       Date:  2013-12-16       Impact factor: 3.090

10.  Two cases of Mycoplasma pneumoniae pneumonia with A2063G mutation in the 23S rRNA gene in siblings.

Authors:  Joo Hee Hong; Jin Kyong Chun; Young Uh; Ki Jin Oh; Juwon Kim; Kap Jun Yoon
Journal:  Ann Lab Med       Date:  2012-12-17       Impact factor: 3.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.